Assignee
CHEMOMAB LTD
IL·4 granted patents·2 pending applications·1 citations·filing 2015–2022
Top patents by PatentIndex Score
6 records- 0165US12018074B2Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseasesCHEMOMAB LTD·Filed 2022·Granted Jun 25, 2024·0 cites·4 claims
- 0265US10479830B2Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokinesCHEMOMAB LTD·Filed 2019·Granted Nov 19, 2019·1 cites·12 claims
- 0349US2023235037A1Method of treatment using anti-ccl24 antibodyCHEMOMAB LTD·Filed 2021·Application pending·0 cites
- 0446US11365246B2Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseasesCHEMOMAB LTD·Filed 2018·Granted Jun 21, 2022·0 cites·4 claims
- 0546US2023192836A1Ccl24 inhibitors in the treatment of covid-19CHEMOMAB LTD·Filed 2021·Application pending·0 cites
- 0639US10246508B2Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokinesCHEMOMAB LTD·Filed 2015·Granted Apr 2, 2019·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when CHEMOMAB LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →